Cargando…

Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure

To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaoka, Ryota, Soejima, Yukako, Guro, Sayuri, Yoshioka, Hideki, Sato, Hiromi, Suzuki, Hiroshi, Hisaka, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452295/
https://www.ncbi.nlm.nih.gov/pubmed/34218511
http://dx.doi.org/10.1002/psp4.12676
_version_ 1784570036167376896
author Takaoka, Ryota
Soejima, Yukako
Guro, Sayuri
Yoshioka, Hideki
Sato, Hiromi
Suzuki, Hiroshi
Hisaka, Akihiro
author_facet Takaoka, Ryota
Soejima, Yukako
Guro, Sayuri
Yoshioka, Hideki
Sato, Hiromi
Suzuki, Hiroshi
Hisaka, Akihiro
author_sort Takaoka, Ryota
collection PubMed
description To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart failure with reduced ejection fraction (HFrEF), reporting changes in heart rate, blood pressure, or ventricular volumes after treatment with carvedilol, metoprolol, bisoprolol, bucindolol, enalapril, aliskiren, or felodipine, were analyzed. Seven cardiac and vasculature function indices were estimated without invasive measurements using models based on appropriate assumptions, and their correlations with the mortality were assessed. Estimated myocardial oxygen consumption, a cardiac load index, correlated excellently with the mortality at 3, 6, and 12 months after treatment initiation, and it explained differences in mortality across the different medications. The analysis based on the present models were reasonably consistent with the hypothesis that the treatment of HFrEF with various medications is due to effectively reducing the cardiac load. Assessment of circulatory physiological parameters by using MBMA would be insightful for quantitative understanding of CHF treatment.
format Online
Article
Text
id pubmed-8452295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84522952021-09-27 Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure Takaoka, Ryota Soejima, Yukako Guro, Sayuri Yoshioka, Hideki Sato, Hiromi Suzuki, Hiroshi Hisaka, Akihiro CPT Pharmacometrics Syst Pharmacol Research To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart failure with reduced ejection fraction (HFrEF), reporting changes in heart rate, blood pressure, or ventricular volumes after treatment with carvedilol, metoprolol, bisoprolol, bucindolol, enalapril, aliskiren, or felodipine, were analyzed. Seven cardiac and vasculature function indices were estimated without invasive measurements using models based on appropriate assumptions, and their correlations with the mortality were assessed. Estimated myocardial oxygen consumption, a cardiac load index, correlated excellently with the mortality at 3, 6, and 12 months after treatment initiation, and it explained differences in mortality across the different medications. The analysis based on the present models were reasonably consistent with the hypothesis that the treatment of HFrEF with various medications is due to effectively reducing the cardiac load. Assessment of circulatory physiological parameters by using MBMA would be insightful for quantitative understanding of CHF treatment. John Wiley and Sons Inc. 2021-07-16 2021-09 /pmc/articles/PMC8452295/ /pubmed/34218511 http://dx.doi.org/10.1002/psp4.12676 Text en © 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research
Takaoka, Ryota
Soejima, Yukako
Guro, Sayuri
Yoshioka, Hideki
Sato, Hiromi
Suzuki, Hiroshi
Hisaka, Akihiro
Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title_full Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title_fullStr Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title_full_unstemmed Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title_short Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
title_sort model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452295/
https://www.ncbi.nlm.nih.gov/pubmed/34218511
http://dx.doi.org/10.1002/psp4.12676
work_keys_str_mv AT takaokaryota modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT soejimayukako modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT gurosayuri modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT yoshiokahideki modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT satohiromi modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT suzukihiroshi modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure
AT hisakaakihiro modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure